Cho LW - Search Results

1

Patients on levothyroxine replacement in the community: association between hypothyroidism symptoms, co-morbidities and their quality of life.

Tan NC, Chew RQ, Subramanian RC, Sankari U, Koh YLE, Cho LW. Tan NC, et al. Among authors: cho lw. Fam Pract. 2019 May 23;36(3):269-275. doi: 10.1093/fampra/cmy064. Fam Pract. 2019. PMID: 30010746

2

Primary hypothyroidism in the community: Lower daily dosages of levothyroxine replacement therapy for Asian patients.

Tan NC, Chew RQ, Koh YLE, Subramanian RC, Sankari U, Meyappan M, Cho LW. Tan NC, et al. Among authors: cho lw. Medicine (Baltimore). 2017 Feb;96(7):e6145. doi: 10.1097/MD.0000000000006145. Medicine (Baltimore). 2017. PMID: 28207545 Free PMC article.

3

Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD.

Bruinstroop E, Dalan R, Cao Y, Bee YM, Chandran K, Cho LW, Soh SB, Teo EK, Toh SA, Leow MKS, Sinha RA, Sadananthan SA, Michael N, Stapleton HM, Leung C, Angus PW, Patel SK, Burrell LM, Lim SC, Sum CF, Velan SS, Yen PM. Bruinstroop E, et al. Among authors: cho lw. J Clin Endocrinol Metab. 2018 Jul 1;103(7):2698-2706. doi: 10.1210/jc.2018-00475. J Clin Endocrinol Metab. 2018. PMID: 29718334 Clinical Trial.

4

HbA1c may not be a sensitive determinant of diabetic status in the elderly.

Tay TL, Foo JP, Tan E, Chen R, Khoo J, Soh SB, Au V, Cho LW. Tay TL, et al. Among authors: cho lw. Diabetes Res Clin Pract. 2011 May;92(2):e31-3. doi: 10.1016/j.diabres.2011.01.003. Epub 2011 Feb 1. Diabetes Res Clin Pract. 2011. PMID: 21281973

5

Sensitivity of A1C to diagnose diabetes is decreased in high-risk older Southeast Asians.

Khoo J, Tay TL, Foo JP, Tan E, Soh SB, Chen R, Au V, Jen-Min Ng B, Cho LW. Khoo J, et al. Among authors: cho lw. J Diabetes Complications. 2012 Mar-Apr;26(2):99-101. doi: 10.1016/j.jdiacomp.2012.02.007. Epub 2012 Mar 31. J Diabetes Complications. 2012. PMID: 22465399

6

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.

Cho LW, Sathyapalan T, Kilpatrick ES, Keevil BG, Miller AG, Coady AM, Ahmed L, Atkin SL. Cho LW, et al. BMC Endocr Disord. 2017 May 19;17(1):26. doi: 10.1186/s12902-017-0177-3. BMC Endocr Disord. 2017. PMID: 28525998 Free PMC article.

7

A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.

Sathyapalan T, Cho LW, Kilpatrick ES, Coady AM, Atkin SL. Sathyapalan T, et al. Among authors: cho lw. Clin Endocrinol (Oxf). 2008 Dec;69(6):931-5. doi: 10.1111/j.1365-2265.2008.03260.x. Epub 2008 Apr 10. Clin Endocrinol (Oxf). 2008. PMID: 18410553 Clinical Trial.

8

Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS).

Sathyapalan T, Cho LW, Kilpatrick ES, Coady AM, Atkin SL. Sathyapalan T, et al. Among authors: cho lw. Clin Endocrinol (Oxf). 2009 Jan;70(1):124-8. doi: 10.1111/j.1365-2265.2008.03345.x. Clin Endocrinol (Oxf). 2009. PMID: 19128368 Clinical Trial.

9

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.

Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL. Cho LW, et al. Clin Endocrinol (Oxf). 2009 Feb;70(2):233-7. doi: 10.1111/j.1365-2265.2008.03309.x. Epub 2008 Jun 10. Clin Endocrinol (Oxf). 2009. PMID: 18547343 Clinical Trial.

10

Cardiovascular risk in women with polycystic ovary syndrome.

Cho LW, Atkin SL. Cho LW, et al. Minerva Endocrinol. 2007 Dec;32(4):263-73. Minerva Endocrinol. 2007. PMID: 18091663 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page